Page last updated: 2024-08-24

torbafylline and Burns

torbafylline has been researched along with Burns in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balasubramaniam, A; Friend, LA; James, JH; Joshi, R; Kadeer, N; Sheriff, S	1

Other Studies

1 other study(ies) available for torbafylline and Burns

Article	Year
Phosphodiesterase (PDE) inhibitor torbafylline (HWA 448) attenuates burn-induced rat skeletal muscle proteolysis through the PDE4/cAMP/EPAC/PI3K/Akt pathway. Molecular and cellular endocrinology, 2014, Aug-05, Volume: 393, Issue:1-2 Topics: Animals; Burns; Cyclic Nucleotide Phosphodiesterases, Type 4; Male; Models, Biological; Muscle, Skeletal; Pentoxifylline; Phosphatidylinositol 3-Kinases; Phosphodiesterase Inhibitors; Proteolysis; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction	2014

Article

Year

Phosphodiesterase (PDE) inhibitor torbafylline (HWA 448) attenuates burn-induced rat skeletal muscle proteolysis through the PDE4/cAMP/EPAC/PI3K/Akt pathway.

Molecular and cellular endocrinology, 2014, Aug-05, Volume: 393, Issue:1-2

Topics: Animals; Burns; Cyclic Nucleotide Phosphodiesterases, Type 4; Male; Models, Biological; Muscle, Skeletal; Pentoxifylline; Phosphatidylinositol 3-Kinases; Phosphodiesterase Inhibitors; Proteolysis; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction

2014